BIOCHEMICAL EVALUATION OF INDUS VIVA I PULSE NATURAL AYURVEDIC SYRUP AND IT’S IN SILICO – INTERACTION ANALYSIS
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i12.49266Keywords:
Amylase, Osteosarcoma, Microbial, Docking, Ayurvedic and HerbalAbstract
Objectives: In developing countries like India, diabetes mellitus and human bone cancer are progressively increasing which is global encumbrance. The objective of the study is to find out the phytoconstituents of Indus Viva I Pulse health drink extract that has undergone classical chemical characterization, molecular docking, anti-diabetic, anticancer, antibacterial and antifungal studies used as traditional and complementary medicine. The study aimed to evaluate the Gas Chromatography–Mass Spectrometry (GC-MS), High-Performance Liquid Chromatography (HPLC), Liquid Chromatography–High Resolution Mass Spectrometry (LC-HRMS), anticancer, antidiabetic and spectral studies that are used to disclose phytochemicals and their medicinal properties.
Methods: Infrared (IR), Ultraviolet (UV), 1H-NMR spectroscopic methods, GC-MS, HPLC and LC-HRMS instrumental detections were employed. Molecular docking, anti-diabetic, anticancer, antibacterial and antifungal studies were carried out using AutoDock 4.2.6. software program, α- Amylase method, Mosmann and Disk diffusion method respectively.
Results: GC-MS and HPLC chromatogram of methanol extracts exhibited 12 and 6 peaks, respectively, confirming the presence of 12 phytoconstituents in Indus Viva I Pulse health drink (1I–12I). The total phenol and flavonoid content found in the extracted sample of Indus Viva I Pulse health drink were 0.16 and 0.36 mg/mL, respectively. It is a polyherbal formulation of brown-colored liquid of the UV spectrum in methanol is characteristic of an aromatic compound with λ max of 319 and 412 nm. IR spectrum gave peaks at 3,457, 2,922, 2,857, 2,121, 1,641, 1,055, 1,033 and 621 cm-1 indicating the presence of an alcoholic, alkyl, aldehyde or ketone, alkyne, carbonyl, anhydride and methyl group, respectively. Liquid Chromatography- High Resolution Mass Spectrometry (LC-HRMS) study gave these molecular weights (m/z): 1134. 7017, 1150.6475 and 1168.6797. Aromatic characteristics were confirmed through UV, IR, 1H-NMR, 13C-NMR and LC-HRMS spectral studies. 1H-NMR study indicates the presence of aromatic protons and methyl protons. Aqueous extract of Indus Viva I Pulse health drink was tested for Cytotoxicity Assay of human bone cancer (MG-63) cell lines and ptyalin prevent characters that exhibited a valid inhibitory value of 90.87% in 10 μg/mL for MG-63 and value of 74.41% in 500 μg/mL for alpha-amylase which is comparatively more efficient than the available standard drug. Cytotoxicity assay for human bone cancer (MG-63) cell lines and alpha-amylase both showed the inhibitory activity of IC50 68.95 and IC50 36.18 μg/mL, respectively.
Conclusion: Based on the result of this research, it can be proposed that Indus Viva I Pulse health drink may serve as a potential remedy for human bone cancer (MG-63) cell line and that alpha-amylase inhibitory activity is proportional to the dose.
Downloads
References
Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. A randomized, prospective trial of the addition of ifosfamide and/or muramyltripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005;23:2004-11. doi: 10.1200/ JCO.2005.06.031
Campanacci M. Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment. 2nd ed., Vol. 2. New York: Springer- Verlag; 1999. p. 5-90. doi: 10.1177/107327480501200102
Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of Osteosarcoma: A review. Sarcoma 2011;2011:959248.
Gorlick R, Khanna C. Osteosarcoma. J Bone Miner Res 2010;25:683- 91. doi: 10.1002/jbmr.77
Messerschmitt PJ, Garcia RM, Abdul-Karim FM, Greenfield EM, Getty PJ. Osteosarcoma. J Am Acad Orthop Surg 2009;17:515-27. doi: 10.5435/00124635-200908000-00005
Yin SY, Wei WC, Jian FY, Yang NS. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Altern Med 2013;2013:302426. doi: 10.1155/2013/302426
Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in type 2 diabetes. Diabetes Med 1990;7:27-30. doi: 10.1155/2010/213176
Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12. doi: 10.2337/diabetes.48.1.1
Funke I, Melzig MF. Traditionally used plants in diabetes therapy phytotherapeutics as inhibitors of α-amylase activity. Braz J Pharm 2006;16:1-5. doi: 10.4236/oalib.1107291
Bandaranayake WM. Traditional and medicinal uses of mangroves. Mangroves Salt Marshes 1998:2:133-48. doi: 10.1023/A:1009988607044
Bhimba BV, Meenupriyaa J, Joel EL, Naveena DE, Kumar S, Thangaraj M. Antibacterial activity and characterization of secondary metabolites isolated from mangrove plant Avicennia officinalis. Asian Pac J Trop Med 2010;3:544-6. doi:10.1016/S1995-7645(10)60131-9
Das G, Gouda S, Mohanta YK, Patra JK. Mangrove plants: A potential source for anticancer drugs. Indian J Geo-Marine Sci 2015;44:666-72. doi: 10.4103/pm.pm_201_18
Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100:72-9. doi:10.1016/j.jep.2005.05.011
Vineet CJ, Natvarlal MP, Dhiren PS, Paras KP, Bhavesh HJ. Antioxidant and antimicrobial activities of Bryophyllum calycinum salisb leaf. Pharmacologyonline 2010;1:393-405.
Gupta R, Lohani M, Arora S. Anti-inflammatory activity of the leaf extracts/fractions of Bryophyllum pinnatum saliv. SYN Int J Pharm Sci Rev Res 2010;3:16-8.
Ojewole AO. Antihypertensive properties of Bryophyllum pinnatum (Lam.) Oken leaf extracts. Am J Hypertens 2002;15:34.
Prasanth NV, Dilip C, Dev S, Augustine L, Saraswathi R. Evaluation of in vitro cytotoxic and antioxidant activities of Ipomoea batatas. Int J Pharm Pharm Sci 2010;2:91-2. doi: 10.1080/10942912.2011.573117
Umadevi M, Kumar KP, Bhowmik D, Duraivel S. Traditionally used anticancer herbs in India. J Med Plants Stud 2013;1:56-74. doi: 10.30574/gscbps.2022.19.3.0214
Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, et al. Characterization of a cis-diamminedichloroplatinum(II)- resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 1987;47:414-8.
Behrens BC, Louie KG, Hamilton TC, Curt G, Kinsetla T, Young RC, et al. Resistance and cross-resistance of human ovarian cancer cell lines to Adriamycin, melphalan, and irradiation. Proc Am Assoc Cancer Res 1984;25:336.
Fan CW, Fan HA, Hsu SH, Chan CC, Chen SY, Hsu YH, et al. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer. Cancer Lett 2004;214:181-8.
Dong HQ, Li M, Zhu F, Liu FL, Huang JB. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. Food Chem 2012;130:261-6.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr. T.H. Mohamed Ahadu Shareef
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.